{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:16:34Z","timestamp":1791850594782,"version":"4.3.4"},"reference-count":85,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2015,12,23]],"date-time":"2015-12-23T00:00:00Z","timestamp":1450828800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Institute of Health","award":["DA034106"],"award-info":[{"award-number":["DA034106"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Multicomponent reactions (MCRs) are extremely popular owing to their facile execution, high atom-efficiency and the high diversity of products. MCRs can be used to access various heterocycles and highly functionalized scaffolds, and thus have been invaluable tools in total synthesis, drug discovery and bioconjugation. Traditional isocyanide-based MCRs utilize an external nucleophile attacking the reactive nitrilium ion, the key intermediate formed in the reaction of the imine and the isocyanide. However, when reactants with multiple nucleophilic groups (bisfunctional reactants) are used in the MCR, the nitrilium intermediate can be trapped by an intramolecular nucleophilic attack to form various heterocycles. The implications of nitrilium trapping along with widely applied conventional isocyanide-based MCRs in drug design are discussed in this review.<\/jats:p>","DOI":"10.3390\/molecules21010019","type":"journal-article","created":{"date-parts":[[2015,12,23]],"date-time":"2015-12-23T07:10:20Z","timestamp":1450854620000},"page":"19","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":134,"title":["Isocyanide-Based Multicomponent Reactions for the Synthesis of Heterocycles"],"prefix":"10.3390","volume":"21","author":[{"given":"Andr\u00e1s","family":"V\u00e1radi","sequence":"first","affiliation":[{"name":"Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travis","family":"Palmer","sequence":"additional","affiliation":[{"name":"Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Notis Dardashti","sequence":"additional","affiliation":[{"name":"Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susruta","family":"Majumdar","sequence":"additional","affiliation":[{"name":"Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2015,12,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1002\/cber.19610940844","article-title":"Erweiterter anwendungsbereich der passerini-reaktion","volume":"94","author":"Ugi","year":"1961","journal-title":"Chem. Ber."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"4231","DOI":"10.1021\/ol0482893","article-title":"Stereochemical control of the passerini reaction","volume":"6","author":"Andreana","year":"2004","journal-title":"Org. Lett."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"9667","DOI":"10.1021\/jo050549m","article-title":"Catalytic, enantioselective \u03b1-additions of isocyanides: Lewis base catalyzed passerini-type reactions","volume":"70","author":"Denmark","year":"2005","journal-title":"J. Org. Chem."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/anie.200704315","article-title":"Catalytic enantioselective passerini three-component reaction","volume":"47","author":"Wang","year":"2008","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1021\/ol100012y","article-title":"Passerini three-component reaction of alcohols under catalytic aerobic oxidative conditions","volume":"12","author":"Brioche","year":"2010","journal-title":"Org. Lett."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1021\/jo900354e","article-title":"Direct alkylative passerini reaction of aldehydes, isocyanides, and free aliphatic alcohols catalyzed by indium(III) triflate","volume":"74","author":"Yanai","year":"2009","journal-title":"J. Org. Chem."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"5021","DOI":"10.1021\/ol0617502","article-title":"O-Arylative Passerini reactions","volume":"8","author":"Gizolme","year":"2006","journal-title":"Org. Lett."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"6031","DOI":"10.1021\/ma401125j","article-title":"Tunable polymers obtained from Passerini multicomponent reaction derived acrylate monomers","volume":"46","author":"Sehlinger","year":"2013","journal-title":"Macromolecules"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"10239","DOI":"10.1021\/jo701978v","article-title":"A flexible six-component reaction to access constrained depsipeptides based on a dihydropyridinone core","volume":"72","author":"Paravidino","year":"2007","journal-title":"J. Org. Chem."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"5456","DOI":"10.1039\/C4CC10091C","article-title":"Enhanced reactivity of dendrons in the Passerini three-component reaction","volume":"51","author":"Jee","year":"2015","journal-title":"Chem. Commun."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"8682","DOI":"10.1002\/anie.201402665","article-title":"Photocaging of carboxylic acids: A modular approach","volume":"53","author":"Velema","year":"2014","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ejmech.2012.09.033","article-title":"Novel peptidomimetic compounds containing redox active chalcogens and quinones as potential anticancer agents","volume":"58","author":"Shaaban","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/j.bmc.2014.01.005","article-title":"Synthesis of novel, peptidic kinase inhibitors with cytostatic\/cytotoxic activity","volume":"22","author":"Szymanski","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1021\/ja109203d","article-title":"Synthesis of optically pure 4-fluoro-glutamines as potential metabolic imaging agents for tumors","volume":"133","author":"Qu","year":"2011","journal-title":"J. Am. Chem. Soc."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1021\/ol0711265","article-title":"Application of ring-closing metathesis for the synthesis of macrocyclic peptidomimetics as inhibitors of hcv ns3 protease","volume":"9","author":"Venkatraman","year":"2007","journal-title":"Org. Lett."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.1021\/ol101763w","article-title":"O-Silylative Passerini reaction: A new one-pot synthesis of \u03b1-siloxyamides","volume":"12","author":"Soeta","year":"2010","journal-title":"Org. Lett."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3688","DOI":"10.1021\/acs.joc.5b00131","article-title":"A one-pot o-sulfinative passerini\/oxidation reaction: Synthesis of \u03b1-(sulfonyloxy)amide derivatives","volume":"80","author":"Soeta","year":"2015","journal-title":"J. Org. Chem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"5007","DOI":"10.1002\/chem.201304618","article-title":"A one-pot o-phosphinative passerini\/pudovik reaction: Efficient synthesis of highly functionalized \u03b1-(phosphinyloxy)amide derivatives","volume":"20","author":"Soeta","year":"2014","journal-title":"Chem. Eur. J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1002\/chem.200802140","article-title":"Applications of multicomponent reactions to the synthesis of diverse heterocyclic scaffolds","volume":"15","author":"Sunderhaus","year":"2009","journal-title":"Chem.-Eur. J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/S0040-4039(99)00072-6","article-title":"Preparation of tricyclic nitrogen heterocycles via tandem four-component condensation\/intramolecular Diels-Alder reaction","volume":"40","author":"Paulvannan","year":"1999","journal-title":"Tetrahedron Lett."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3762\/bjoc.10.50","article-title":"Isocyanide-based multicomponent reactions towards cyclic constrained peptidomimetics","volume":"10","author":"Koopmanschap","year":"2014","journal-title":"Beilstein J. Org. Chem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"4351","DOI":"10.1021\/ol061755z","article-title":"Rapid access to oxindoles by the combined use of an Ugi four-component reaction and a microwave-assisted intramolecular buchwald\u2212hartwig amidation reaction","volume":"8","author":"Bonnaterre","year":"2006","journal-title":"Org. Lett."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nchem.1062","article-title":"Contemporary strategies for peptide macrocyclization","volume":"3","author":"White","year":"2011","journal-title":"Nat. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1021\/ol048850x","article-title":"Titanium catalysis in the Ugi reaction of \u03b1-amino acids with aromatic aldehydes","volume":"6","author":"Godet","year":"2004","journal-title":"Org. Lett."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"5595","DOI":"10.1021\/jo800745a","article-title":"Catalysis of Ugi four component coupling reactions by rare earth metal triflates","volume":"73","author":"Okandeji","year":"2008","journal-title":"J. Org. Chem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1021\/cr100233r","article-title":"Chemistry and biology of multicomponent reactions","volume":"112","author":"Wang","year":"2012","journal-title":"Chem. Rev."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/j.tetlet.2012.01.079","article-title":"Zinc chloride catalyzed three-component Ugi reaction: Synthesis of n-cyclohexyl-2-(2-hydroxyphenylamino)acetamide derivatives","volume":"53","author":"Shaabani","year":"2012","journal-title":"Tetrahedron Lett."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.1002\/anie.200800494","article-title":"Catalytic three-component Ugi reaction","volume":"47","author":"Pan","year":"2008","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"6234","DOI":"10.1002\/anie.201006515","article-title":"Multicomponent reaction design in the quest for molecular complexity and diversity","volume":"50","author":"Ruijter","year":"2011","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"5506","DOI":"10.1039\/c2ra20539d","article-title":"Formation of unexpected [small alpha]-amino amidine through three-component \u201cUgi condensation reaction\u201d","volume":"2","author":"Khan","year":"2012","journal-title":"RSC Adv."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"7961","DOI":"10.1002\/anie.200502636","article-title":"Phenol Ugi\u2013smiles systems: Strategies for the multicomponent n-arylation of primary amines with isocyanides, aldehydes, and phenols","volume":"44","author":"Grimaud","year":"2005","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"4019","DOI":"10.1021\/ol061605o","article-title":"Direct access to heterocyclic scaffolds by new multicomponent Ugi\u2212Smiles couplings","volume":"8","author":"Gizolme","year":"2006","journal-title":"Org. Lett."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1002\/1521-3773(20000915)39:18<3168::AID-ANIE3168>3.0.CO;2-U","article-title":"Multicomponent reactions with isocyanides","volume":"39","author":"Ugi","year":"2000","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2174\/0929867033368600","article-title":"\u201cMulti-component reactions: Emerging chemistry in drug discovery\u201d \u201cfrom xylocain to crixivan\u201d","volume":"10","author":"Hulme","year":"2003","journal-title":"Curr. Med. Chem."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1021\/ol9028622","article-title":"Isolation of Ugi four-component condensation primary adducts: A straightforward route to isocoumarins","volume":"12","author":"Faggi","year":"2010","journal-title":"Org. Lett."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"5285","DOI":"10.1021\/ol052239w","article-title":"Exploiting the dual reactivity of o-isocyanobenzamide: Three-component synthesis of 4-imino-4H-3,1-benzoxazines","volume":"7","author":"Bonne","year":"2005","journal-title":"Org. Lett."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1055\/s-1998-1721","article-title":"Synthesis of imidazo[1,2-a] annulated pyridines, pyrazines and pyrimidines by a novel three-component condensation","volume":"6","author":"Groebke","year":"1998","journal-title":"Synlett"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1016\/S0040-4039(98)00653-4","article-title":"Parallel synthesis of 3-aminoimidazo[1,2-a]pyridines and pyrazines by a new three-component condensation","volume":"39","author":"Blackburn","year":"1998","journal-title":"Tetrahedron Lett."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1002\/(SICI)1521-3773(19980904)37:16<2234::AID-ANIE2234>3.0.CO;2-R","article-title":"A new heterocyclic multicomponent reaction for the combinatorial synthesis of fused 3-aminoimidazoles","volume":"37","author":"Bouzid","year":"1998","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11030-008-9072-1","article-title":"Emerging approaches for the syntheses of bicyclic imidazo[1,2-x]-heterocycles","volume":"12","author":"Hulme","year":"2008","journal-title":"Mol. Divers."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.tet.2014.10.032","article-title":"Diversity-oriented synthesis of fused-imidazole derivatives via Groebke\u2013Blackburn\u2013Bienayme reaction: A review","volume":"71","author":"Devi","year":"2015","journal-title":"Tetrahedron"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.bmcl.2011.01.001","article-title":"Scaffold oriented synthesis. Part 4: Design, synthesis and biological evaluation of novel 5-substituted indazoles as potent and selective kinase inhibitors employing heterocycle forming and multicomponent reactions","volume":"21","author":"Wakefield","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"5013","DOI":"10.1021\/jm200235u","article-title":"N-Fused imidazoles as novel anticancer agents that inhibit catalytic activity of topoisomerase II\u03b1 and induce apoptosis in g1\/s phase","volume":"54","author":"Baviskar","year":"2011","journal-title":"J. Med. Chem."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"5850","DOI":"10.1016\/j.bmc.2012.07.052","article-title":"Antibacterial activities of groebke-blackburn-bienayme-derived imidazo[1,2-a]pyridin-3-amines","volume":"20","author":"Shukla","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"10058","DOI":"10.1021\/ja204016e","article-title":"Combinatorial discovery of fluorescent pharmacophores by multicomponent reactions in droplet arrays","volume":"133","author":"Burchak","year":"2011","journal-title":"J. Am. Chem. Soc."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Elleder, D., Baiga, T., Russell, R., Naughton, J., Hughes, S., Noel, J., and Young, J. (2012). Identification of a 3-aminoimidazo[1,2-a]pyridine inhibitor of hiv-1 reverse transcriptase. Virol. J., 9.","DOI":"10.1186\/1743-422X-9-305"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"4227","DOI":"10.1016\/j.bmc.2011.05.062","article-title":"Imidazo[1,2-a]pyridin-3-amines as potential HIV-1 non-nucleoside reverse transcriptase inhibitors","volume":"19","author":"Bode","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1021\/ar800214s","article-title":"Strategies for innovation in multicomponent reaction design","volume":"42","author":"Ganem","year":"2009","journal-title":"Acc. Chem. Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1021\/cc7001777","article-title":"Novel isocyanide-based three-component synthesis of 3,4-dihydroquinoxalin-2-amine derivatives","volume":"10","author":"Shaabani","year":"2008","journal-title":"J. Comb. Chem."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1021\/ol2034542","article-title":"[5 + 1] cycloaddition of c,n-cyclic n\u2032-acyl azomethine imines with isocyanides","volume":"14","author":"Soeta","year":"2012","journal-title":"Org. Lett."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"4708","DOI":"10.1021\/ja401701x","article-title":"Synthesis of substituted pyridines from cascade [1 + 5] cycloaddition of isonitriles to n-formylmethyl-substituted enamides, aerobic oxidative aromatization, and acyl transfer reaction","volume":"135","author":"Lei","year":"2013","journal-title":"J. Amer. Chem. Soc."},{"key":"ref_52","unstructured":"Shutske, G.M., Kapples, K.J., Tomer, J.D., Hrib, N.J., and Jurcak, J.J. (1991). Substituted-4-amino-3-pyridinols, a Process for Their Preparation and Their Use as Medicaments. (EP0477903 A2)."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"7279","DOI":"10.1002\/anie.201201905","article-title":"A catalytic asymmetric Ugi-type reaction with acyclic azomethine imines","volume":"51","author":"Hashimoto","year":"2012","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"11772","DOI":"10.1021\/ja0644374","article-title":"Versatile, fragrant, convertible isonitriles","volume":"128","author":"Pirrung","year":"2006","journal-title":"J. Am. Chem. Soc."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1039\/c2sc20669b","article-title":"A chemical synthesis of 11-methoxy mitragynine pseudoindoxyl featuring the interrupted ugi reaction","volume":"3","author":"Kim","year":"2012","journal-title":"Chem. Sci."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1016\/j.tet.2008.08.055","article-title":"An interrupted Ugi reaction enables the preparation of substituted indoxyls and aminoindoles","volume":"65","author":"Schneekloth","year":"2009","journal-title":"Tetrahedron"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"6239","DOI":"10.1016\/j.tetlet.2007.07.044","article-title":"Tmscl-promoted isocyanide-based mcr of ethylenediamines: An efficient assembling of 2-aminopyrazine core","volume":"48","author":"Kysil","year":"2007","journal-title":"Tetrahedron Lett."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1021\/jo4000702","article-title":"Catalytic ugi-type condensation of \u03b1-isocyanoacetamide and chiral cyclic imine: Access to asymmetric construction of several heterocycles","volume":"78","author":"Xia","year":"2013","journal-title":"J. Org. Chem."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1016\/j.bmcl.2013.02.109","article-title":"Design and synthesis of 2-substituted benzoxazoles as novel ptp1b inhibitors","volume":"23","author":"Chandrasekharappa","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/S0968-0896(99)00136-4","article-title":"Heterocyclic analogues of l-citrulline as inhibitors of the isoforms of nitric oxide synthase (nos) and identification of n\u03b4-(4,5-dihydrothiazol-2-yl)ornithine as a potent inhibitor","volume":"7","author":"Ulhaq","year":"1999","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1021\/cr020033s","article-title":"The combinatorial synthesis of bicyclic privileged structures or privileged substructures","volume":"103","author":"Horton","year":"2003","journal-title":"Chem. Rev."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1021\/jm7012979","article-title":"Novel non-peptide nociceptin\/orphanin fq receptor agonist, 1-[1-(1-methylcyclooctyl)-4-piperidinyl]-2-[(3R)-3-piperidinyl]-1H-benzimidazole: Design, synthesis, and structure\u2212activity relationship of oral receptor occupancy in the brain for orally potent antianxiety drug(1, 2)","volume":"52","author":"Hayashi","year":"2009","journal-title":"J. Med. Chem."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"4529","DOI":"10.1021\/jm800176x","article-title":"Synthesis of new arylpiperazinylalkylthiobenzimidazole, benzothiazole, or benzoxazole derivatives as potent and selective 5-ht1a serotonin receptor ligands\u2020","volume":"51","author":"Siracusa","year":"2008","journal-title":"J. Med. Chem."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1021\/ol500328t","article-title":"Three-component coupling approach for the synthesis of diverse heterocycles utilizing reactive nitrilium trapping","volume":"16","author":"Varadi","year":"2014","journal-title":"Org. Lett."},{"key":"ref_65","first-page":"1241","article-title":"Synthetic strategies towards benzoxazole ring systems: A review","volume":"16","author":"Kumar","year":"2004","journal-title":"Asian J. Chem."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"4959","DOI":"10.1016\/S0040-4039(01)00919-4","article-title":"Two-step solution-phase synthesis of novel benzimidazoles utilizing a udc (Ugi\/de-Boc\/cyclize) strategy","volume":"42","author":"Tempest","year":"2001","journal-title":"Tetrahedron Lett."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"6256","DOI":"10.1021\/ol202725y","article-title":"A powerful palladium-catalyzed multicomponent process for the preparation of oxazolines and benzoxazoles","volume":"13","author":"Boissarie","year":"2011","journal-title":"Org. Lett."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"9030","DOI":"10.1016\/j.tetlet.2007.10.067","article-title":"Diversity oriented synthesis of benzoxazoles and benzothiazoles","volume":"48","author":"Spatz","year":"2007","journal-title":"Tetrahedron Lett."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1016\/j.tet.2008.12.002","article-title":"Beyond the ugi reaction: Less conventional interactions between isocyanides and iminium species","volume":"65","author":"Grimaud","year":"2009","journal-title":"Tetrahedron"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"7084","DOI":"10.1002\/anie.201300942","article-title":"Palladium-catalyzed migratory insertion of isocyanides: An emerging platform in cross-coupling chemistry","volume":"52","author":"Vlaar","year":"2013","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1021\/jm5002088","article-title":"Development of a bioavailable mu opioid receptor (mopr) agonist, delta opioid receptor (dopr) antagonist peptide that evokes antinociception without development of acute tolerance","volume":"57","author":"Mosberg","year":"2014","journal-title":"J. Med. Chem."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"E118","DOI":"10.1208\/aapsj080114","article-title":"Opioid ligands with mixed mu\/delta opioid receptor interactions: An emerging approach to novel analgesics","volume":"8","author":"Ananthan","year":"2006","journal-title":"AAPS J."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"3527","DOI":"10.1021\/jm990039i","article-title":"Synthesis, opioid receptor binding, and biological activities of naltrexone-derived pyrido- and pyrimidomorphinans","volume":"42","author":"Ananthan","year":"1999","journal-title":"J. Med. Chem."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1021\/jm980724+","article-title":"The opioid \u03bc agonist\/\u03b4 antagonist dipp-nh2[\u03c8] produces a potent analgesic effect, no physical dependence, and less tolerance than morphine in rats","volume":"42","author":"Schiller","year":"1999","journal-title":"J. Med. Chem."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"7724","DOI":"10.1021\/jm9007483","article-title":"Pentapeptides displaying mu opioid receptor agonist and delta opioid receptor partial agonist\/antagonist properties","volume":"52","author":"Purington","year":"2009","journal-title":"J. Med. Chem."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1124\/jpet.110.172866","article-title":"In vivo characterization of mmp-2200, a mixed delta\/mu opioid agonist, in mice","volume":"336","author":"Lowery","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1124\/jpet.108.138180","article-title":"Behavioral pharmacology of the \u03bc\/\u03b4 opioid glycopeptide mmp2200 in rhesus monkeys","volume":"326","author":"Polt","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0014-2999(92)90685-W","article-title":"Pharmacological profiles of fentanyl analogs at mu, delta and kappa opiate receptors","volume":"213","author":"Maguire","year":"1992","journal-title":"Eur. J. Pharmacol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1016\/j.tetlet.2010.03.120","article-title":"Ugi reaction for the synthesis of 4-aminopiperidine-4-carboxylic acid derivatives. Application to the synthesis of carfentanil and remifentanil","volume":"51","author":"Malaquin","year":"2010","journal-title":"Tetrahedron Lett."},{"key":"ref_80","unstructured":"Pentel, P.R., Portoghese, P.S., Pravetoni, M., and Naour, M.C.P.L. (2014). Compositions and Methods of Treating Opioid Addiction. (US20140093525 A1)."},{"key":"ref_81","unstructured":"Portoghese, P., and Eyup, A. (2014). Analgesic Conjugates. (WO2014124317 A1)."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1021\/acschemneuro.5b00137","article-title":"Synthesis of carfentanil amide opioids using the ugi multicomponent reaction","volume":"6","author":"Palmer","year":"2015","journal-title":"ACS Chem. Neurosci."},{"key":"ref_83","first-page":"377","article-title":"Design, synthesis and sar of analgesics","volume":"291","author":"Srulevitch","year":"1989","journal-title":"Prog. Clin. Biol. Res."},{"key":"ref_84","first-page":"89","article-title":"4-phenylamidopiperidines: Synthesis, pharmacological testing and sar analysis","volume":"41","author":"Srulevitch","year":"1991","journal-title":"Acta Pharm. Jugosl."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"5162","DOI":"10.1073\/pnas.90.11.5162","article-title":"Blockade of tolerance to morphine but not to kappa opioids by a nitric oxide synthase inhibitor","volume":"90","author":"Kolesnikov","year":"1993","journal-title":"Proc. Nat. Acad. Sci. USA"}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/21\/1\/19\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T20:54:42Z","timestamp":1760216082000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/21\/1\/19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,23]]},"references-count":85,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,1]]}},"alternative-id":["molecules21010019"],"URL":"https:\/\/doi.org\/10.3390\/molecules21010019","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,23]]}}}